In ARD, Ramiro et al report a number of sophisticated primary and sensitivity analyses from
an observational cohort study conducted in the Netherlands during the height of the COVID …

Objectives: The primary objective was to evaluate ICU mortality at 28 days in patients with
severe hypoxemic respiratory failure due to coronavirus disease 2019 infection who …

Targeting the renin-angiotensin system is proposed to affect mortality due to coronavirus
disease 2019 (COVID-19). We aimed to compare the mortality rates in COVID-19 patients …

Objectives This study aimed to assess if tocilizumab (TCZ) timing is associated with
improved survival. Material and methods Data obtained from adult patients with …

Purpose There may be a difference in respiratory mechanics, inflammatory markers, and
pulmonary emboli in COVID-19 associated ARDS vs. ARDS from other etiologies. Our …

Abstract Coronavirus Disease 2019 (COVID‐19) has become a global pandemic in 2020
with high patient mortality due to acute respiratory distress syndrome which is possibly …

COVID-19 infection is associated with systemic inflammation, and sometimes
hyperinflammatory responses with cytokine storm. This plays a major role in COVID-19 …

Background Tocilizumab (TCZ), an interleukin-6 receptor antibody, has previously been
used for treating patients with the coronavirus disease 2019 (COVID-19), but there is a lack …

OBJECTIVES: We designed this study to test whether clazakizumab, a direct interleukin-6
inhibitor, benefits patients hospitalized with severe or critical COVID-19 disease …

Background The objective of this study is to describe incidence and shifts of serotype and
clonal distribution of invasive Streptococcus pneumoniae strains in four different age groups …